Prognostic factors and staging in multiple myeloma: a reappraisal.

A new look at the statistical model identification

1974 • 46,507 citations

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Information Theory and an Extension of the Maximum Likelihood Principle

1998 • 16,234 citations

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

1977 • 8,468 citations

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

1965 • 3,333 citations

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1975 • 3,051 citations

Analysis of Binary Data

2008 • 2,760 citations

The Analysis of Binary Data.

1971 • 2,339 citations

Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma

1980 • 269 citations

Prognostic factors in multiple myeloma

1975 • 235 citations

Serum beta₂ microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.

1983 • 179 citations

Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients

1984 • 175 citations

Ploidy and proliferative characteristics in monoclonal gammopathies

1982 • 149 citations

Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging

1982 • 130 citations

Comparison of bone scintigraphy and radiography in multiple myeloma.

1980 • 129 citations

Serum β 2-microglobulin in myelomatosis: potential value in stratification and monitoring

1980 • 88 citations

Prognostic relevance of cellular morphology in multiple myeloma

1984 • 88 citations

Multi-sample cluster analysis using Akaike's Information Criterion

1984 • 83 citations

Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders.

1984 • 81 citations

Human myeloma in vitro colony growth: interrelationships between drug sensitivity, cell kinetics, and patient survival duration

1983 • 79 citations

Multiple myeloma: quantitative staging and assessment of response with a programmable pocket calculator

1977 • 77 citations

Serum beta-2-microglobulin in multiple myeloma: Relation to presenting features and clinical status

1982 • 56 citations

Bone scintigraphy in plasma-cell myeloma. A prospective study of 70 patients.

1982 • 54 citations

Evaluation of serum β 2-microglobulin as a prognostic indicator in myelomatosis

1983 • 48 citations

Prognostic Factors in Multiple Myeloma

1978 • 42 citations

Factors influencing the prognosis in myelomatosis

1971 • 37 citations

Bone Healing in Multiple Myeloma with Melphalan Chemotherapy

1972 • 36 citations

Clinical evaluation of myeloma osteoclastic bone lesions: II. Induced hypocalcemia test using salmon calcitonin

1982 • 23 citations

Urea, albumin, and response rates.

1971 • 17 citations

Acute effects of salmon calcitonin in multiple myeloma: a valuable method for serial evaluation of osteoclastic lesions and disease activity--a prospective study of 125 patients.

1985 • 14 citations